Navigation Links
Bioinformatics Market Worth $7.5 Billion by 2017
Date:6/18/2013

DALLAS, June 18, 2013 /PRNewswire/ --

The "Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Global Forecasts to 2017", analyzes and studies the Major Market Drivers, Restraints, and Opportunities in North America, Europe, Asia-Pacific and Rest of World.

Browse

  • 120 Market Data Tables
  • 22 Figures
  • 364 Pages and an in-depth Table of Content on "Bioinformatics Market"

http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

Early buyers will receive 10% customization on this report.

This report studies the global Bioinformatics Market over the forecast period 2012-2017.

The Global Bioinformatics Market was valued at $2.9 billion in 2012 and is poised to reach $7.5 billion by 2017 at a CAGR of 20.9%. Bioinformatics Technologies are used in various pharmaceutical and biotechnology sectors to support their growth.

Major sectors that use bioinformatics tools and services are:

  • Medicine
  • Agriculture
  • Environment
  • Animal
  • Forensic
  • Academics
  • Others (Home Land Security & Defense, Law-Enforcement Groups, Bio-Weapon Creation, and Evolutionary Biotechnology).

The Medical Sector accounted for the lion's share of the Bioinformatics Market, owing to the increasing use of bioinformatics in the drug discovery and development process.

Product and services in the Bioinformatics Market comprise of Platforms, Knowledge Management Tools, and Services. The Bioinformatics Platforms Market is the fastest-growing segment, as they play a crucial role in quick and easy analysis and manipulation of large amounts of data obtained from NGS projects.

Applications of Bioinformatics in Life Sciences Research include Genomics, Proteomics, Chemoinformatics, Molecular Phylogenetics, Metabolomics, Transcriptomics, and others (Glycomics, Cytomics, Physiomics and Interactomics). Genomics commands the largest share of the bioinformatics application market.

The decreasing cost of DNA sequencing, increasing funding from government and private organizations, and technical advancements in bioinformatics tools and platforms are propelling the market. Dearth of a common data format for integration of data, lack of well-defined standards, and shortage of skilled bioinformatics professionals are major hurdles to growth of the market. It is expected that the market will offer growth opportunities for bioinformatics solutions manufacturers with the introduction and adoption of upcoming technologies such as nanopore sequencing and cloud computing.

North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. However, other regions such as Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry-academia partnerships.

 Buy a copy of this Report @http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=39

 Browse related reports to Healthcare Information Technology Market @http://www.marketsandmarkets.com/healthcare-information-technology-171.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, healthcare information technology, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004)
2. Bioinformatics: Technologies and Global Markets
3. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
4. Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
5. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
6. Scientists Warn of Long Term Consequences of Budget Sequestration: BioInformatics LLC Report
7. BioInformatics LLC Multi-Sponsor Market Report – In-depth Exploration of the U.S. Market for Biosimilar Drugs
8. Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
9. BioInformatics LLC New Market Report – Best Practices Guide for Advertising to Life Scientists
10. BioInformatics LLC Webcast – The Life Science Product Manger’s Toolkit
11. BioInformatics LLC New Market Report – Opportunities for New Players in the Growing Stem Cell Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), a ... a majority-owned subsidiary of Intrexon Corporation (NYSE: ... of its common shares on the NASDAQ Stock Market ... "AquaBounty,s listing on NASDAQ represents an important milestone for ... U.S. markets as we advance plans for commercial production ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... organization with services spanning the full spectrum of drug and device development, and ... services to pharma/device companies and clinicians, today announced Verified Clinical Trials ...
(Date:1/19/2017)... FRANKLIN LAKES, N.J. , Jan. 18, 2017 BD ... medical technology company, announced today that it will host a live ... 2017, at 1 p.m. (ET). The webcast can ... will be available for replay through Tuesday, January 31, 2017. ... About BD ...
(Date:1/18/2017)... 18, 2017 Applied BioMath ( www.appliedbiomath.com ... drug research and development, today announced that Dr. ... CEO of Applied BioMath, will present at the ... (BAGIM) Meeting on Thursday January 19, 2017 at ... , MA.   Dr. Burke,s talk "Quantitative Modeling and ...
Breaking Biology Technology:
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/12/2017)... PORTLAND, Oregon and PUNE, India , January 12, 2017 ... Technology Market: Opportunities and Forecasts, 2015 - 2022," projects that the global biometric technology ... CAGR of 19.4% from 2016 to 2022. Continue Reading ... ... ...
(Date:1/11/2017)... N.J. , Jan. 11, 2017  Michael Johnson, co-founder of ... Venture Capital Group, Inc., has been named to the elite "Forbes ... 27,  was one of 600 people in 20 fields nationwide to ... percent of the 15,000 applicants were selected. ... He is currently a PhD candidate at ...
Breaking Biology News(10 mins):